Cancer stem cells (CSCs) contribute to multidrug resistance, tumor recurrence and metastasis, making them prime therapeutic targets. Their ability to differentiate and lose stem cell properties makes them challenging to study. Currently, there is no simple assay that can capture and trace the dynamic phenotypic changes on the CSC surface. Here, we report rapid discrimination of breast CSCs from non-CSCs using a nanoparticle-fluorescent-protein based sensor. This nanosensor was employed to discriminate CSCs from non-CSCs, as well CSCs that had differentiated in vitro in two breast cancer models. Importantly, the sensor platform could also discriminate CSCs from the bulk population of cells in patient-derived xenografts of human breast cancer...
Breast cancer is categorized as the most widespread cancer type among women globally. On-time diagno...
Profiling the heterogeneous phenotypes of rare circulating tumour cells (CTCs) in whole blood is cri...
Cancer stem cells (CSCs) are currently known as the main cause of tumor recurrence. After chemothera...
Rapid and effective differentiation between normal and cancer cells is an important challenge for th...
Profiling the heterogeneous phenotypes of individual circulating tumor cells (CTCs) from patients is...
The detection of circulating tumor cells (CTCs) from blood samples can predict prognosis, response t...
In tissue engineering and regenerative medicine, monitoring the status of stem cell differentiation ...
We report a nanosensor that uses cell lysates to rapidly profile the tumorigenicity of cancer cells....
Effective identification of breast cancer stem cells (CSC) benefits from a multiplexed approach to d...
Cell surface harbors rich information regarding the status of cell health. Being able to monitor and...
Following exposure to human plasma (HP), nanoparticles (NPs) are coated with a biomolecular layer re...
According to WHO and other key statistics, cancer is a leading cause of death worldwide, accounting ...
International audienceAbstract The detection of cancer stem-like cells (CSCs) is mainly based on mol...
Nanotechnologies are emerging platforms that could be useful in measuring, understanding, and manipu...
Nanobiosensors have played a key role as portable devices in the rapid breast cancer diagnosis and i...
Breast cancer is categorized as the most widespread cancer type among women globally. On-time diagno...
Profiling the heterogeneous phenotypes of rare circulating tumour cells (CTCs) in whole blood is cri...
Cancer stem cells (CSCs) are currently known as the main cause of tumor recurrence. After chemothera...
Rapid and effective differentiation between normal and cancer cells is an important challenge for th...
Profiling the heterogeneous phenotypes of individual circulating tumor cells (CTCs) from patients is...
The detection of circulating tumor cells (CTCs) from blood samples can predict prognosis, response t...
In tissue engineering and regenerative medicine, monitoring the status of stem cell differentiation ...
We report a nanosensor that uses cell lysates to rapidly profile the tumorigenicity of cancer cells....
Effective identification of breast cancer stem cells (CSC) benefits from a multiplexed approach to d...
Cell surface harbors rich information regarding the status of cell health. Being able to monitor and...
Following exposure to human plasma (HP), nanoparticles (NPs) are coated with a biomolecular layer re...
According to WHO and other key statistics, cancer is a leading cause of death worldwide, accounting ...
International audienceAbstract The detection of cancer stem-like cells (CSCs) is mainly based on mol...
Nanotechnologies are emerging platforms that could be useful in measuring, understanding, and manipu...
Nanobiosensors have played a key role as portable devices in the rapid breast cancer diagnosis and i...
Breast cancer is categorized as the most widespread cancer type among women globally. On-time diagno...
Profiling the heterogeneous phenotypes of rare circulating tumour cells (CTCs) in whole blood is cri...
Cancer stem cells (CSCs) are currently known as the main cause of tumor recurrence. After chemothera...